BackConduit Pharmaceuticals- Warrants (22/09/2028) Overview

Conduit Pharmaceuticals- Warrants (22/09/2028) Current Cash

Conduit Pharmaceuticals- Warrants (22/09/2028)'s current cash is $270M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$272.15M
↑ 5.08% YoYΔ $13.15M vs prior year quarter

Peer average

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) Current Cash History

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) vs. peers: Current Cash Comparison

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Conduit Pharmaceuticals- Warrants (22/09/2028) (CDTTW) FAQ

As of the most recent data (March 2026), CDTTW shows a current cash of $270M. That compares with $260M in the prior-year period — up 5.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDTTW's current cash is now $270M (was $260M) — a 5.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Conduit Pharmaceuticals- Warrants (22/09/2028) is outperforming or lagging.

Tracking CDTTW's current cash over time shows whether Conduit Pharmaceuticals- Warrants (22/09/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $270M That compares with $260M in the prior-year period — up 5.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Conduit Pharmaceuticals- Warrants (22/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $270M) with ownership activity and broader fundamentals.